Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Bönisch H[au]:

The role of cysteines and histidins of the norepinephrine transporter. Wenge B et al. Neurochem Res. (2013)

Effects of opioids on human serotonin transporters. Barann M et al. Naunyn Schmiedebergs Arch Pharmacol. (2015)

An engineered affibody molecule with pH-dependent binding to FcRn mediates extended circulatory half-life of a fusion protein. Seijsing J et al. Proc Natl Acad Sci U S A. (2014)

Search results

Items: 1 to 50 of 165

1.

An engineered affibody molecule with pH-dependent binding to FcRn mediates extended circulatory half-life of a fusion protein.

Seijsing J, Lindborg M, Höidén-Guthenberg I, Bönisch H, Guneriusson E, Frejd FY, Abrahmsén L, Ekblad C, Löfblom J, Uhlén M, Gräslund T.

Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17110-5. doi: 10.1073/pnas.1417717111. Epub 2014 Nov 18.

2.

Effects of opioids on human serotonin transporters.

Barann M, Stamer UM, Lyutenska M, Stüber F, Bönisch H, Urban B.

Naunyn Schmiedebergs Arch Pharmacol. 2015 Jan;388(1):43-9. doi: 10.1007/s00210-014-1056-3. Epub 2014 Oct 22.

PMID:
25332055
3.

Natural compounds boldine and menthol are antagonists of human 5-HT3 receptors: implications for treating gastrointestinal disorders.

Walstab J, Wohlfarth C, Hovius R, Schmitteckert S, Röth R, Lasitschka F, Wink M, Bönisch H, Niesler B.

Neurogastroenterol Motil. 2014 Jun;26(6):810-20. doi: 10.1111/nmo.12334. Epub 2014 Apr 8.

PMID:
24708203
4.

The role of cysteines and histidins of the norepinephrine transporter.

Wenge B, Bönisch H.

Neurochem Res. 2013 Jul;38(7):1303-14. doi: 10.1007/s11064-013-1022-3. Epub 2013 Mar 23.

PMID:
23525969
5.

Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3.

Haenisch B, Drescher E, Thiemer L, Xin H, Giros B, Gautron S, Bönisch H.

Naunyn Schmiedebergs Arch Pharmacol. 2012 Oct;385(10):1017-23. doi: 10.1007/s00210-012-0781-8. Epub 2012 Jul 18.

PMID:
22806583
6.

Inhibitory potencies of trimipramine and its main metabolites at human monoamine and organic cation transporters.

Haenisch B, Hiemke C, Bönisch H.

Psychopharmacology (Berl). 2011 Sep;217(2):289-95. doi: 10.1007/s00213-011-2281-9. Epub 2011 Apr 12.

PMID:
21484238
7.

Pharmacological characterization of tegaserod at the wild type and 124Cys variant of the human 5-HT1B receptor.

Haenisch B, Bönisch H.

Pharmacogenet Genomics. 2011 Jul;21(7):432-5. doi: 10.1097/FPC.0b013e3283469f1d.

PMID:
21478802
8.

Differences between human wild-type and C23S variant 5-HT2C receptors in inverse agonist-induced resensitization.

Walstab J, Steinhagen F, Brüss M, Göthert M, Bönisch H.

Pharmacol Rep. 2011;63(1):45-53.

9.

Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).

Pick A, Müller H, Mayer R, Haenisch B, Pajeva IK, Weigt M, Bönisch H, Müller CE, Wiese M.

Bioorg Med Chem. 2011 Mar 15;19(6):2090-102. doi: 10.1016/j.bmc.2010.12.043. Epub 2010 Dec 30.

PMID:
21354800
10.

Effects of exogenous agmatine in human leukemia HMC-1 and HL-60 cells on proliferation, polyamine metabolism and cell cycle.

Haenisch B, Bönisch H, Cichon S, Allam JP, Novak N, Molderings GJ.

Leuk Res. 2011 Sep;35(9):1248-53. doi: 10.1016/j.leukres.2010.12.023. Epub 2011 Jan 14.

PMID:
21236489
11.

Oxybutynin and trospium are substrates of the human organic cation transporters.

Wenge B, Geyer J, Bönisch H.

Naunyn Schmiedebergs Arch Pharmacol. 2011 Feb;383(2):203-8. doi: 10.1007/s00210-010-0590-x. Epub 2011 Jan 7.

PMID:
21212936
12.

Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters.

Haenisch B, Bönisch H.

Pharmacol Ther. 2011 Mar;129(3):352-68. doi: 10.1016/j.pharmthera.2010.12.002. Epub 2010 Dec 13. Review.

PMID:
21147164
13.

Chlorine isotope fractionation in the stratosphere.

Laube JC, Kaiser J, Sturges WT, Bönisch H, Engel A.

Science. 2010 Sep 3;329(5996):1167. doi: 10.1126/science.1191809.

14.

Src family kinase inhibitor Saracatinib (AZD0530) impairs oxaliplatin uptake in colorectal cancer cells and blocks organic cation transporters.

Morrow CJ, Ghattas M, Smith C, Bönisch H, Bryce RA, Hickinson DM, Green TP, Dive C.

Cancer Res. 2010 Jul 15;70(14):5931-41. doi: 10.1158/0008-5472.CAN-10-0694. Epub 2010 Jun 15.

15.

RIC-3 exclusively enhances the surface expression of human homomeric 5-hydroxytryptamine type 3A (5-HT3A) receptors despite direct interactions with 5-HT3A, -C, -D, and -E subunits.

Walstab J, Hammer C, Lasitschka F, Möller D, Connolly CN, Rappold G, Brüss M, Bönisch H, Niesler B.

J Biol Chem. 2010 Aug 27;285(35):26956-65. doi: 10.1074/jbc.M110.122838. Epub 2010 Jun 3.

16.

Inhibitory and facilitory actions of isocyanine derivatives at human and rat organic cation transporters 1, 2 and 3: a comparison to human alpha 1- and alpha 2-adrenoceptor subtypes.

Amphoux A, Millan MJ, Cordi A, Bönisch H, Vialou V, Mannoury la Cour C, Dupuis DS, Giros B, Gautron S.

Eur J Pharmacol. 2010 May 25;634(1-3):1-9. doi: 10.1016/j.ejphar.2010.02.012. Epub 2010 Feb 17.

PMID:
20170649
17.

Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline.

Haenisch B, Walstab J, Herberhold S, Bootz F, Tschaikin M, Ramseger R, Bönisch H.

Fundam Clin Pharmacol. 2010 Dec;24(6):729-39. doi: 10.1111/j.1472-8206.2009.00805.x.

PMID:
20030735
18.

Interaction of the human plasma membrane monoamine transporter (hPMAT) with antidepressants and antipsychotics.

Haenisch B, Bönisch H.

Naunyn Schmiedebergs Arch Pharmacol. 2010 Jan;381(1):33-9. doi: 10.1007/s00210-009-0479-8. Epub 2009 Dec 10.

PMID:
20012264
19.

Characterization of the naturally occurring Arg344His variant of the human 5-HT 3A receptor.

Combrink S, Kostanian A, Walstab J, Barann M, Brüss M, Göthert M, Bönisch H.

Pharmacol Rep. 2009 Sep-Oct;61(5):785-97.

20.

Interference of the noradrenergic neurotoxin DSP4 with neuronal and nonneuronal monoamine transporters.

Wenge B, Bönisch H.

Naunyn Schmiedebergs Arch Pharmacol. 2009 Dec;380(6):523-9. doi: 10.1007/s00210-009-0459-z. Epub 2009 Oct 17.

PMID:
19838680
21.

Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression.

Haenisch B, Bilkei-Gorzo A, Caron MG, Bönisch H.

J Neurochem. 2009 Oct;111(2):403-16. doi: 10.1111/j.1471-4159.2009.06345.x. Epub 2009 Aug 18.

22.

Association of major depression with rare functional variants in norepinephrine transporter and serotonin1A receptor genes.

Haenisch B, Linsel K, Brüss M, Gilsbach R, Propping P, Nöthen MM, Rietschel M, Fimmers R, Maier W, Zobel A, Höfels S, Guttenthaler V, Göthert M, Bönisch H.

Am J Med Genet B Neuropsychiatr Genet. 2009 Oct 5;150B(7):1013-6. doi: 10.1002/ajmg.b.30912.

PMID:
19105200
23.

Regulatory mechanisms underlying agmatine homeostasis in humans.

Haenisch B, von Kügelgen I, Bönisch H, Göthert M, Sauerbruch T, Schepke M, Marklein G, Höfling K, Schröder D, Molderings GJ.

Am J Physiol Gastrointest Liver Physiol. 2008 Nov;295(5):G1104-10. doi: 10.1152/ajpgi.90374.2008. Epub 2008 Oct 2.

24.

Naturally occurring variants in the HTR3B gene significantly alter properties of human heteromeric 5-hydroxytryptamine-3A/B receptors.

Walstab J, Hammer C, Bönisch H, Rappold G, Niesler B.

Pharmacogenet Genomics. 2008 Sep;18(9):793-802. doi: 10.1097/FPC.0b013e3283050117.

PMID:
18698232
25.

First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome.

Kapeller J, Houghton LA, Mönnikes H, Walstab J, Möller D, Bönisch H, Burwinkel B, Autschbach F, Funke B, Lasitschka F, Gassler N, Fischer C, Whorwell PJ, Atkinson W, Fell C, Büchner KJ, Schmidtmann M, van der Voort I, Wisser AS, Berg T, Rappold G, Niesler B.

Hum Mol Genet. 2008 Oct 1;17(19):2967-77. doi: 10.1093/hmg/ddn195. Epub 2008 Jul 9.

PMID:
18614545
26.

Learning and memory in 5-HT(1A)-receptor mutant mice.

Bert B, Fink H, Rothe J, Walstab J, Bönisch H.

Behav Brain Res. 2008 Dec 16;195(1):78-85. doi: 10.1016/j.bbr.2008.02.028. Epub 2008 Mar 10. Review.

PMID:
18396339
27.

N-Ethylmaleimide differentially inhibits substrate uptake by and ligand binding to the noradrenaline transporter.

Wenge B, Bönisch H.

Naunyn Schmiedebergs Arch Pharmacol. 2008 May;377(3):255-65. doi: 10.1007/s00210-008-0272-0. Epub 2008 Mar 21.

PMID:
18357440
28.

Neurotrophin and neuropeptide expression in mouse brain is regulated by knockout of the norepinephrine transporter.

Haenisch B, Gilsbach R, Bönisch H.

J Neural Transm (Vienna). 2008 Jul;115(7):973-82. doi: 10.1007/s00702-008-0039-2. Epub 2008 Mar 12.

PMID:
18335160
29.

Separation of membrane proteins by two-dimensional electrophoresis using cationic rehydrated strips.

Wenge B, Bönisch H, Grabitzki J, Lochnit G, Schmitz B, Ahrend MH.

Electrophoresis. 2008 Apr;29(7):1511-7. doi: 10.1002/elps.200700546.

PMID:
18318447
30.

Molecular cloning and functional expression of the murine noradrenaline transporter.

Muck A, Gilsbach R, Löbbe-Werner S, Brüss M, Bönisch H.

Naunyn Schmiedebergs Arch Pharmacol. 2007 Oct;376(1-2):65-71. Epub 2007 Sep 19.

PMID:
17882401
31.

Ultrahigh-resolution study on Pyrococcus abyssi rubredoxin: II. Introduction of an O-H...Sgamma-Fe hydrogen bond increased the reduction potential by 65 mV.

Bönisch H, Schmidt CL, Bianco P, Ladenstein R.

J Biol Inorg Chem. 2007 Nov;12(8):1163-71. Epub 2007 Aug 22.

PMID:
17712580
32.

Aequorin luminescence-based assay for 5-hydroxytryptamine (serotonin) type 3 receptor characterization.

Walstab J, Combrink S, Brüss M, Göthert M, Niesler B, Bönisch H.

Anal Biochem. 2007 Sep 15;368(2):185-92. Epub 2007 Jun 8.

PMID:
17617370
33.

S1P-receptors in PC12 and transfected HEK293 cells: molecular targets of hypotensive imidazoline I(1) receptor ligands.

Molderings GJ, Bönisch H, Brüss M, Wolf C, von Kügelgen I, Göthert M.

Neurochem Int. 2007 Dec;51(8):476-85. Epub 2007 May 7.

PMID:
17559976
34.

[The pharmacology of benzodiazepines].

Bönisch H.

Pharm Unserer Zeit. 2007;36(3):186-94. Review. German. No abstract available.

PMID:
17555054
35.

Characterization of the novel human serotonin receptor subunits 5-HT3C,5-HT3D, and 5-HT3E.

Niesler B, Walstab J, Combrink S, Möller D, Kapeller J, Rietdorf J, Bönisch H, Göthert M, Rappold G, Brüss M.

Mol Pharmacol. 2007 Jul;72(1):8-17. Epub 2007 Mar 28.

PMID:
17392525
36.

The norepinephrine transporter in physiology and disease.

Bönisch H, Brüss M.

Handb Exp Pharmacol. 2006;(175):485-524. Review.

PMID:
16722247
37.

Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain.

Amphoux A, Vialou V, Drescher E, Brüss M, Mannoury La Cour C, Rochat C, Millan MJ, Giros B, Bönisch H, Gautron S.

Neuropharmacology. 2006 Jun;50(8):941-52. Epub 2006 Mar 31.

PMID:
16581093
38.

Effect of antidepressant drugs in mice lacking the norepinephrine transporter.

Dziedzicka-Wasylewska M, Faron-Górecka A, Kuśmider M, Drozdowska E, Rogóz Z, Siwanowicz J, Caron MG, Bönisch H.

Neuropsychopharmacology. 2006 Nov;31(11):2424-32. Epub 2006 Mar 22.

39.

Comparison of in vitro and in vivo reference genes for internal standardization of real-time PCR data.

Gilsbach R, Kouta M, Bönisch H, Brüss M.

Biotechniques. 2006 Feb;40(2):173-7.

40.

Effects of tramadol and O-demethyl-tramadol on human 5-HT reuptake carriers and human 5-HT3A receptors: a possible mechanism for tramadol-induced early emesis.

Barann M, Urban B, Stamer U, Dorner Z, Bönisch H, Brüss M.

Eur J Pharmacol. 2006 Feb 15;531(1-3):54-8. Epub 2006 Jan 19.

PMID:
16427041
41.

Norepinephrine transporter knockout-induced up-regulation of brain alpha2A/C-adrenergic receptors.

Gilsbach R, Faron-Górecka A, Rogóz Z, Brüss M, Caron MG, Dziedzicka-Wasylewska M, Bönisch H.

J Neurochem. 2006 Feb;96(4):1111-20. Epub 2006 Jan 17.

42.

Ultrahigh-resolution study on Pyrococcus abyssi rubredoxin. I. 0.69 A X-ray structure of mutant W4L/R5S.

Bönisch H, Schmidt CL, Bianco P, Ladenstein R.

Acta Crystallogr D Biol Crystallogr. 2005 Jul;61(Pt 7):990-1004. Epub 2005 Jun 24.

PMID:
15983423
43.

Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.

Brüss M, Kiel S, Bönisch H, Kostanian A, Göthert M.

Neurochem Int. 2005 Aug;47(3):196-203.

PMID:
15896881
44.

The naturally occurring Arg219Leu variant of the human 5-HT1A receptor: impairment of signal transduction.

Brüss M, Kostanian A, Bönisch H, Göthert M.

Pharmacogenet Genomics. 2005 Apr;15(4):257-64.

PMID:
15864118
45.

Functional importance of the C-terminus of the human norepinephrine transporter.

Distelmaier F, Wiedemann P, Brüss M, Bönisch H.

J Neurochem. 2004 Nov;91(3):537-46.

46.

Pharmacological and electrophysiological properties of the naturally occurring Pro391Arg variant of the human 5-HT3A receptor.

Kurzwelly D, Barann M, Kostanian A, Combrink S, Bönisch H, Göthert M, Brüss M.

Pharmacogenetics. 2004 Mar;14(3):165-72.

PMID:
15167704
47.

Influence of sodium substitutes on 5-HT-mediated effects at mouse 5-HT3 receptors.

Barann M, Schmidt K, Göthert M, Urban BW, Bönisch H.

Br J Pharmacol. 2004 Jun;142(3):501-8. Epub 2004 May 17.

48.
49.

Identification and pharmacological characterization of a specific agmatine transport system in human tumor cell lines.

Molderings GJ, Bruss M, Bonisch H, Gothert M.

Ann N Y Acad Sci. 2003 Dec;1009:75-81.

PMID:
15028572
50.

Use of the norepinephrine transporter as a reporter gene for non-invasive imaging of genetically modified cells.

Anton M, Wagner B, Haubner R, Bodenstein C, Essien BE, Bönisch H, Schwaiger M, Gansbacher B, Weber WA.

J Gene Med. 2004 Jan;6(1):119-26.

PMID:
14716684

Supplemental Content

Loading ...
Support Center